FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Enalaprilat Injection
Status: Currently in Shortage
»Date first posted: 03/29/2019
»Therapeutic Categories: Cardiovascular

Expand all

Hikma Pharmaceuticals USA, Inc. (Revised 04/16/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Enalaprilat Injection, USP, Injection, 2.5 mg/2 mL (NDC 0143-9786-10)	Unavailable	Additional lots will be scheduled for manufacturing. Product will be made available as it is released.	Demand increase for the drug
Enalaprilat Injection, USP, Injection, 1.25 mg/1 mL (NDC 0143-9787-10)	Available	Additional lots will be scheduled for manufacturing. Product will be made available as it is released.